Corrigendum

Corrigendum to “Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug and Alcohol Dependence, 105(1–2), 2009, 83–88.

Amy Nunn^a,b,*, Nickolas Zaller^a,b,c, Samuel Dickman^a, Catherine Trimbur^d, Anka Nijhawan^a,b and Josiah D. Rich^a,b,c

^aAlpert Medical School of Brown University, Division of Infectious Diseases, 164 Summit Avenue, Providence, RI 02906, USA

^bThe Miriam Hospital, 164 Summit Avenue, Providence, RI 02906, USA

^cCenter for Prisoner Health and Human Rights, Providence, RI 02906USA

^dUniversity of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA

*Corresponding author at: Alpert Medical School of Brown University, Division of Infectious Diseases, 164 Summit Avenue, Providence, RI 02906, USA; amy_nunn@brown.edu

In this paper, we surveyed the medical directors of state, federal, and District of Columbia prison systems about their opinions and prescribing practices for methadone and buprenorphine. Our survey also included questions about prison policies related to referring prisoners to community-based opiate replacement therapy (ORT) programs upon release. A color-coded map was used to illustrate states’ prescribing and referral policies (Fig. 1). The original map indicated that the District of Columbia offered only ORT referrals. We found in our survey, however, that the District of Columbia offered both ORT and ORT referrals and was thus mislabeled on the map as medium blue instead of dark blue. Below is the correct Fig. 1.

Fig 1.

Current status of state prison systems offering opiate replacement therapy (ORT) and referrals to community-based ORT providers